Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alcolea

Showing results (111-120 of 242) with videos related to

Pageof 25
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 4, 2020
Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderlyJordi Pegueroles, Adriana Pané, Eduard Vilaplana, et al.
JAMA Network Open|August 5, 2022
Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down SyndromeLaura Videla, Bessy Benejam, Jordi Pegueroles, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2014
Posttranslational nitro-glycative modifications of albumin in Alzheimer's disease: implications in cytotoxicity and amyloid-β peptide aggregationEva Ramos-Fernández, Marta Tajes, Ernest Palomer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 11, 2023
Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndromeLaura Videla, Bessy Benejam, María Carmona-Iragui, et al.
International Journal of Molecular Sciences|April 17, 2025
Advancing Personalized Medicine in Alzheimer's Disease: Liquid Biopsy Epigenomics Unveil <i>APOE</i> ε4-Linked Methylation SignaturesMónica Macías, Juan José Alba-Linares, Blanca Acha, et al.
Neurology|December 17, 2024
Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome: A Case ReportÍñigo Rodríguez-Baz, Bessy Benejam, Alejandra O Morcillo-Nieto, et al.
Alzheimer'S Research & Therapy|June 29, 2021
VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndromeAlberto Lleó, Maria Carmona-Iragui, Laura Videla, et al.
Brain Structure & Function|March 26, 2026
Impaired semantic word learning in primary progressive aphasiaGuillem Olivé, Gemma Cardona, María F Porto, et al.
Neurologia|May 27, 2026
Appropriate use recommendations of the Spanish Society of Neurology's Behavioural Neurology and Dementia Study Group on anti-amyloid antibodies in the treatment of Alzheimer diseaseRaquel Sánchez-Valle, Daniel Alcolea, Guillermo Amer Ferrer, et al.
Annals of Clinical and Translational Neurology|April 17, 2025
A Novel CHMP2B Splicing Variant in Atypical Presentation of Familial Frontotemporal Lobar DegenerationSara Rubio-Guerra, Sara Bernal, David Almenta, et al.
Pageof 25

Showing results (111-120 of 242) with videos related to

Sort By:
Pageof 25
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 4, 2020
Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderlyJordi Pegueroles, Adriana Pané, Eduard Vilaplana, et al.
JAMA Network Open|August 5, 2022
Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down SyndromeLaura Videla, Bessy Benejam, Jordi Pegueroles, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2014
Posttranslational nitro-glycative modifications of albumin in Alzheimer's disease: implications in cytotoxicity and amyloid-β peptide aggregationEva Ramos-Fernández, Marta Tajes, Ernest Palomer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 11, 2023
Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndromeLaura Videla, Bessy Benejam, María Carmona-Iragui, et al.
International Journal of Molecular Sciences|April 17, 2025
Advancing Personalized Medicine in Alzheimer's Disease: Liquid Biopsy Epigenomics Unveil <i>APOE</i> ε4-Linked Methylation SignaturesMónica Macías, Juan José Alba-Linares, Blanca Acha, et al.
Neurology|December 17, 2024
Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome: A Case ReportÍñigo Rodríguez-Baz, Bessy Benejam, Alejandra O Morcillo-Nieto, et al.
Alzheimer'S Research & Therapy|June 29, 2021
VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndromeAlberto Lleó, Maria Carmona-Iragui, Laura Videla, et al.
Brain Structure & Function|March 26, 2026
Impaired semantic word learning in primary progressive aphasiaGuillem Olivé, Gemma Cardona, María F Porto, et al.
Neurologia|May 27, 2026
Appropriate use recommendations of the Spanish Society of Neurology's Behavioural Neurology and Dementia Study Group on anti-amyloid antibodies in the treatment of Alzheimer diseaseRaquel Sánchez-Valle, Daniel Alcolea, Guillermo Amer Ferrer, et al.
Annals of Clinical and Translational Neurology|April 17, 2025
A Novel CHMP2B Splicing Variant in Atypical Presentation of Familial Frontotemporal Lobar DegenerationSara Rubio-Guerra, Sara Bernal, David Almenta, et al.
Pageof 25